Connect with us

Business

Eli Lilly COVID-19 combo therapy cuts risk of death, hospitalization by 70%, company says – Fox News

A combination of two Eli Lilly antibody drugs were found to reduce risk of hospitalization and death in high-risk patients recently diagnosed with coronavirus by…

Published

on

post featured image
ADVERTISEMENT

A combination of two Eli Lilly antibody drugs were found to reduce risk of hospitalization and death in high-risk patients recently diagnosed with coronavirus by 70%, the company said Tuesday. The results stem from a Phase 3 BLAZE-1 trial involving 1,035 patients and add to previous data collected during Phase 2 trials.
The trial saw patients given 2800 mg of bamlanivimab and 2800 mg of etesevimab. Among the group given the combination therapy, there were 11 “events,” such as hospitalizations, versus…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
High-priced tech stocks sink further into bear market territory – Financial Times
Article feature image
Fact-checking Detroit mayor’s misleading statements on Johnson & Johnson vaccine – CNN
Article feature image
Ford recalls some of the first Mustang Mach-E SUVs due to loose bolts – The Verge